PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

Global Respiratory Inhalers Market Forecast2021-2031 (Value & Volume): - by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients demonstrated improper usage of epinephrine autoinjectors and metered-dose inhalers, ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

GSK plc announced positive phase III data from its clinical programme to develop a next-generation version of its metered dose inhaler (MDI), Ventolin (salbutamol). Data confirm that the formulation ...

New York, March 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Digital Dose Inhaler Market Research Report by Product, by Type - Global Forecast to 2025 - ...

According to the report, the metered dose inhalers market was valued at $10.1 billion in 2024, and is estimated to reach $18.4 billion by 2034, growing at a CAGR of 6.2% from 2025 to 2034.